No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone

Psychiatry Res. 1995 Aug 8;61(2):67-83. doi: 10.1016/0925-4927(95)02732-d.

Abstract

The dopamine hypothesis of schizophrenia received strong support when a two- to three-fold elevation of D2 receptor densities was demonstrated by positron emission tomography (PET) and [11C]N-methylspiperone ([11C]NMSP). In the present study, the reproducibility of this finding was examined by application of a similar method in seven normal comparison subjects and seven neuroleptic-naive schizophrenic patients examined by PET before and after administration of haloperidol, 7.5 mg. After haloperidol, the specific binding of [11C]NMSP was reduced by 80-90%, resulting in a signal-to-noise ratio that was unfavorably low for reliable quantification. No significant difference was found between normal subjects and patients in a descriptive analysis of the time-activity curves or in a nonequilibrium graphical determination of D2 receptor densities in the basal ganglia. The results are consistent with those of a previous quantitative PET study of [11C]raclopride binding, which showed normal densities of D2 receptors in the striatum of neuroleptic-naive schizophrenic patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Carbon Radioisotopes
  • Cerebellum / diagnostic imaging
  • Cerebellum / drug effects
  • Cerebellum / physiopathology
  • Dopamine Agonists* / pharmacokinetics
  • Female
  • Frontal Lobe / diagnostic imaging
  • Frontal Lobe / drug effects
  • Frontal Lobe / physiopathology
  • Haloperidol / adverse effects
  • Haloperidol / therapeutic use
  • Humans
  • Male
  • Putamen / diagnostic imaging
  • Putamen / drug effects
  • Putamen / physiopathology
  • Radioligand Assay
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / physiology*
  • Reproducibility of Results
  • Schizophrenia / diagnostic imaging*
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology
  • Schizophrenic Psychology*
  • Spiperone / analogs & derivatives*
  • Spiperone / pharmacokinetics
  • Tomography, Emission-Computed*

Substances

  • Carbon Radioisotopes
  • Dopamine Agonists
  • Receptors, Dopamine D2
  • Spiperone
  • 3-N-methylspiperone
  • Haloperidol